Results 131 to 140 of about 3,691,818 (247)
Advances in antibody-drug conjugates in cancer: latest updates from the 2026 AACR annual meeting. [PDF]
Exp Hematol OncolLi YR, Zhu Y, Chen Y.
europepmc +1 more source
Arthritis Care &Research, EarlyView.Objective To evaluate whether extending the American College of Rheumatology–recommended monitoring interval for complete blood count and liver function tests in patients receiving methotrexate (MTX) affects timely detection of medication‐related toxicity.
Spencer Simko +4 more
wiley +1 more source
Emerging artificial intelligence advances in oncology: latest updates from the 2026 AACR annual meeting. [PDF]
J Hematol OncolLi YR, Shao Z, Nan H.
europepmc +1 more source
Caregiver Perspectives on the Burden of Disease and Treatment in Uncontrolled Gout
Arthritis Care &Research, EarlyView.Objective Uncontrolled gout (UG) refers to persistently elevated serum urate (SU) levels >6 mg/dL and ongoing gout symptoms despite use of urate‐lowering therapy (ULT). The objective of this study was to evaluate the burden associated with informal caregiving for individuals with UG.
Angelo Gaffo +6 more
wiley +1 more source
Editorial: New insights in neurodegeneration: highlights from the 42nd Annual Meeting of the Australasian Neuroscience Society (Perth, Western Australia). [PDF]
Front NeurosciHellewell SC +3 more
europepmc +1 more source
Arthritis Care &Research, EarlyView.Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Methods Using data from a single center, we analyzed employment transitions, adjusted mean disease activity ...
Javier Mencia‐Ledo +4 more
wiley +1 more source